Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 257230, 17 pages
http://dx.doi.org/10.1155/2015/257230
Research Article

Angioblast Derived from ES Cells Construct Blood Vessels and Ameliorate Diabetic Polyneuropathy in Mice

1Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
2Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
3Department of Chronic Kidney Disease Initiatives, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, 21 Karimata, Yazako, Nagakute, Aichi 480-1195, Japan
5Department of Internal Medicine, School of Dentistry, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan
6Department of Metabolic Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan

Received 16 December 2014; Revised 24 March 2015; Accepted 25 March 2015

Academic Editor: Raffaele Marfella

Copyright © 2015 Tatsuhito Himeno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Ismail-Beigi, T. Craven, M. A. Banerji et al., “Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial,” The Lancet, vol. 376, no. 9739, pp. 419–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. The Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Publisher · View at Google Scholar
  3. R. Turner, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” The Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. D. K. Wilson, K. M. Bohren, K. H. Gabbay, and F. A. Quiocho, “An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications,” Science, vol. 257, no. 5066, pp. 81–84, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. F. G. Soriano, L. Virág, P. Jagtap et al., “Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation,” Nature Medicine, vol. 7, no. 1, pp. 108–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Giardino, D. Edelstein, and M. Brownlee, “Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: a model for intracellular glycosylation in diabetes,” The Journal of Clinical Investigation, vol. 94, no. 1, pp. 110–117, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Horie, T. Miyata, K. Maeda et al., “Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy,” The Journal of Clinical Investigation, vol. 100, no. 12, pp. 2995–3004, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Lu, M. Kuroki, S. Amano et al., “Advanced glycation end products increase retinal vascular endothelial growth factor expression,” The Journal of Clinical Investigation, vol. 101, no. 6, pp. 1219–1224, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Schmidt, O. Hori, J. X. Chen et al., “Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes,” The Journal of Clinical Investigation, vol. 96, no. 3, pp. 1395–1403, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Shinohara, P. J. Thornalley, I. Giardino et al., “Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis,” The Journal of Clinical Investigation, vol. 101, no. 5, pp. 1142–1147, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. Craven, R. K. Studer, and F. R. DeRubertis, “Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response,” Journal of Clinical Investigation, vol. 93, no. 1, pp. 311–320, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Ishii, M. R. Jirousek, D. Koya et al., “Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor,” Science, vol. 272, no. 5262, pp. 728–731, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Koya and G. L. King, “Protein kinase C activation and the development of diabetic complications,” Diabetes, vol. 47, no. 6, pp. 859–866, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Xia, R. M. Kramer, and G. L. King, “Identification of the mechanism for the inhibition of Na+,K+-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2,” The Journal of Clinical Investigation, vol. 96, no. 2, pp. 733–740, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Kolm-Litty, U. Sauer, A. Nerlich, R. Lehmann, and E. D. Schleicher, “High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells,” The Journal of Clinical Investigation, vol. 101, no. 1, pp. 160–169, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. K. A. Kles and A. I. Vinik, “Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component,” Current Diabetes Reviews, vol. 2, no. 2, pp. 131–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. W. Zochodne, “Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms,” Muscle and Nerve, vol. 36, no. 2, pp. 144–166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Tesfaye, N. Chaturvedi, S. E. M. Eaton et al., “Vascular risk factors and diabetic neuropathy,” The New England Journal of Medicine, vol. 352, no. 4, pp. 341–350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Giannini and P. J. Dyck, “Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus,” Annals of Neurology, vol. 36, no. 3, pp. 408–415, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Yasuda and P. J. Dyck, “Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy,” Neurology, vol. 37, no. 1, pp. 20–28, 1987. View at Publisher · View at Google Scholar · View at Scopus
  21. N. E. Cameron, M. A. Cotter, V. Archibald, K. C. Dines, and E. K. Maxfield, “Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats,” Diabetologia, vol. 37, no. 5, pp. 449–459, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. L. J. Coppey, J. S. Gellett, E. P. Davidson, J. A. Dunlap, D. D. Lund, and M. A. Yorek, “Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve,” Diabetes, vol. 50, no. 8, pp. 1927–1937, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Lin, D. J. Weisdorf, A. Solovey, and R. P. Hebbel, “Origins of circulating endothelial cells and endothelial outgrowth from blood,” The Journal of Clinical Investigation, vol. 105, no. 1, pp. 71–77, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Peichev, A. J. Naiyer, D. Pereira et al., “Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors,” Blood, vol. 95, no. 3, pp. 952–958, 2000. View at Google Scholar · View at Scopus
  26. M. C. Yoder, L. E. Mead, D. Prater et al., “Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals,” Blood, vol. 109, no. 5, pp. 1801–1809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Massa, V. Rosti, M. Ferrario et al., “Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction,” Blood, vol. 105, no. 1, pp. 199–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Shintani, T. Murohara, H. Ikeda et al., “Mobilization of endothelial progenitor cells in patients with acute myocardial infarction,” Circulation, vol. 103, no. 23, pp. 2776–2779, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. J. George, A. Afek, A. Abashidze et al., “Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2636–2641, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-S. Yoon, A. Wecker, L. Heyd et al., “Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction,” The Journal of Clinical Investigation, vol. 115, no. 2, pp. 326–338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. L. Balestrieri, M. Rienzo, F. Felice et al., “High glucose downregulates endothelial progenitor cell number via SIRT1,” Biochimica et Biophysica Acta, vol. 1784, no. 6, pp. 936–945, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. G. P. Fadini, M. Miorin, M. Facco et al., “Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus,” Journal of the American College of Cardiology, vol. 45, no. 9, pp. 1449–1457, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Kränkel, V. Adams, A. Linke et al., “Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 4, pp. 698–703, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. C. J. M. Loomans, E. J. P. de Koning, F. J. T. Staal et al., “Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes,” Diabetes, vol. 53, no. 1, pp. 195–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. O. M. Tepper, R. D. Galiano, J. M. Capla et al., “Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures,” Circulation, vol. 106, no. 22, pp. 2781–2786, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. O. Awad, C. Jiao, N. Ma, M. Dunnwald, and G. C. Schatteman, “Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors,” Stem Cells, vol. 23, no. 4, pp. 575–583, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. K. A. Gallagher, Z.-J. Liu, M. Xiao et al., “Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1249–1259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. E. J. Marrotte, D.-D. Chen, J. S. Hakim, and A. F. Chen, “Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice,” The Journal of Clinical Investigation, vol. 120, no. 12, pp. 4207–4219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Koch, Z. Kokaia, O. Lindvall, and O. Brüstle, “Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling,” The Lancet Neurology, vol. 8, no. 9, pp. 819–829, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. D. G. Phinney and D. J. Prockop, “Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views,” Stem Cells, vol. 25, no. 11, pp. 2896–2902, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Stamm, B. Westphal, H.-D. Kleine et al., “Autologous bone-marrow stem-cell transplantation for myocardial regeneration,” The Lancet, vol. 361, no. 9351, pp. 45–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Chopp and Y. Li, “Treatment of neural injury with marrow stromal cells,” The Lancet Neurology, vol. 1, no. 2, pp. 92–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. K. le Blanc, I. Rasmusson, B. Sundberg et al., “Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells,” The Lancet, vol. 363, no. 9419, pp. 1439–1441, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Naruse, Y. Hamada, E. Nakashima et al., “Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy,” Diabetes, vol. 54, no. 6, pp. 1823–1828, 2005. View at Google Scholar
  45. J. E. Ferguson III, R. W. Kelley, and C. Patterson, “Mechanisms of endothelial differentiation in embryonic vasculogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 11, pp. 2246–2254, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. R. L. Williams, D. J. Hilton, S. Pease et al., “Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells,” Nature, vol. 336, no. 6200, pp. 684–687, 1988. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Narazaki, H. Uosaki, M. Teranishi et al., “Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells,” Circulation, vol. 118, no. 5, pp. 498–506, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Watabe, T. Fukuda, J. Tanaka, H. Honda, K. Toyohara, and O. Sakai, “Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities,” Journal of Neuroscience Research, vol. 41, no. 2, pp. 279–290, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Shibata, K. Naruse, H. Kamiya et al., “Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats,” Diabetes, vol. 57, no. 11, pp. 3099–3107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. J. J. Katims, E. H. Naviasky, L. K. Y. Ng, M. Rendell, and M. L. Bleecker, “New screening device for assessment of peripheral neuropathy,” Journal of Occupational Medicine, vol. 28, no. 12, pp. 1219–1221, 1986. View at Google Scholar · View at Scopus
  51. K. K. Beiswenger, N. A. Calcutt, and A. P. Mizisin, “Epidermal nerve fiber quantification in the assessment of diabetic neuropathy,” Acta Histochemica, vol. 110, no. 5, pp. 351–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Ishitobi, A. Wakamatsu, F. Liu et al., “Molecular basis for FlK1 expression in hemato-cardiovascular progenitors in the mouse,” Development, vol. 138, no. 24, pp. 5357–5368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Iwase, N. Nagaya, T. Fujii et al., “Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia,” Cardiovascular Research, vol. 66, no. 3, pp. 543–551, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Kinnaird, E. S. Burnett, M. Shou et al., “Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms,” Circulation, vol. 109, no. 12, pp. 1543–1549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. I. Masaki, Y. Yonemitsu, A. Yamashita et al., “Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2,” Circulation Research, vol. 90, no. 9, pp. 966–973, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Nakae, H. Kamiya, K. Naruse et al., “Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats,” Diabetes, vol. 55, no. 5, pp. 1470–1477, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Schratzberger, D. H. Walter, K. Rittig et al., “Reversal of experimental diabetic neuropathy by VEGF gene transfer,” The Journal of Clinical Investigation, vol. 107, no. 9, pp. 1083–1092, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Mårin, B. Andersson, M. Krotkiewski, and P. Björntorp, “Muscle fiber composition and capillary density in women and men with NIDDM,” Diabetes Care, vol. 17, no. 5, pp. 382–386, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. J. M. Kennedy and D. W. Zochodne, “Influence of experimental diabetes on the microcirculation of injured peripheral nerve functional and morphological aspects,” Diabetes, vol. 51, no. 7, pp. 2233–2240, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. D. W. Zochodne, “Nerve and ganglion blood flow in diabetes: an appraisal,” International Review of Neurobiology, vol. 50, pp. 161–202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. N. E. Cameron, M. A. Cotter, and S. Robertson, “Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats,” Diabetologia, vol. 35, no. 1, pp. 12–18, 1992. View at Publisher · View at Google Scholar · View at Scopus
  62. I. G. Obrosova, C. Van Huysen, L. Fathallah, X. Cao, M. J. Stevens, and D. A. Greene, “Evaluation of α1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense,” The FASEB Journal, vol. 14, no. 11, pp. 1548–1558, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Okawa, H. Kamiya, T. Himeno et al., “Transplantation of neural crest-like cells derived from induced pluripotent stem cells improves diabetic polyneuropathy in mice,” Cell Transplantation, vol. 22, no. 10, pp. 1767–1783, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. E. A. Masson, A. Veves, D. Fernando, and A. J. M. Boulton, “Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus,” Diabetologia, vol. 32, no. 10, pp. 724–728, 1989. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Matsutomo, K. Takebayashi, and Y. Aso, “Assessment of peripheral neuropathy using measurement of the current perception threshold with the neurometer in patients with type 2 diabetes mellitus,” Journal of International Medical Research, vol. 33, no. 4, pp. 442–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Veves, M. J. Young, C. Manes, and A. J. M. Boulton, “Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a clinical study,” Diabetes Care, vol. 17, no. 10, pp. 1200–1202, 1994. View at Publisher · View at Google Scholar · View at Scopus